Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane combined with dexmedetomidine or esketamine for sedation during dual-source CT in children with congenital heart disease
ChiCTR2400085549Phase 4Not yet recruiting
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane, dexmedetomidine and esketamine in Cardiovascular Malformation (CVM) (3 arms), sponsored by Yan'an Affiliated Hospital of Kunming Medical University. Primary endpoints: Motor responses, Calm maintenance duration and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
sevofluranedexmedetomidineesketamine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2400085549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085549.